"pancreatic cancer" trang 8 - tải miễn phí từ tailieunhanh
TRAIL-receptor preferences in pancreatic cancer cells revisited: Both TRAIL-R1 and TRAIL-R2 have a licence to kill

TRAIL-receptor preferences in pancreatic cancer cells revisited: Both TRAIL-R1 and TRAIL-R2 have a licence to kill
11    26    1
The combination of intravenous Reolysin and gemcitabine induces reovirus replication and endoplasmic reticular stress in a patient with KRAS-activated pancreatic cancer

The combination of intravenous Reolysin and gemcitabine induces reovirus replication and endoplasmic reticular stress in a patient with KRAS-activated pancreatic cancer
5    32    1
Moxifloxacin and ciprofloxacin induces S-phase arrest and augments apoptotic effects of cisplatin in human pancreatic cancer cells via ERK activation

Moxifloxacin and ciprofloxacin induces S-phase arrest and augments apoptotic effects of cisplatin in human pancreatic cancer cells via ERK activation
15    38    1
Human pancreatic cancer stem cells are sensitive to dual inhibition of IGF-IR and ErbB receptors

Human pancreatic cancer stem cells are sensitive to dual inhibition of IGF-IR and ErbB receptors
8    27    1
Valproic acid sensitizes pancreatic cancer cells to natural killer cell-mediated lysis by upregulating MICA and MICB via the PI3K/Akt signaling pathway

Valproic acid sensitizes pancreatic cancer cells to natural killer cell-mediated lysis by upregulating MICA and MICB via the PI3K/Akt signaling pathway
10    48    1
MiR-200a inhibits epithelial-mesenchymal transition of pancreatic cancer stem cell

MiR-200a inhibits epithelial-mesenchymal transition of pancreatic cancer stem cell
9    55    1
Stem cell Transplantation for Eradication of Minimal PAncreatic Cancer persisting after surgical Excision (STEM PACE Trial, ISRCTN47877138): Study protocol for a phase II study

Stem cell Transplantation for Eradication of Minimal PAncreatic Cancer persisting after surgical Excision (STEM PACE Trial, ISRCTN47877138): Study protocol for a phase II study
12    46    1
Interferon-beta enhances sensitivity to gemcitabine in pancreatic cancer

Interferon-beta enhances sensitivity to gemcitabine in pancreatic cancer
15    27    1
PERK, pAKT and p53 as tissue biomarkers in erlotinib-treated patients with advanced pancreatic cancer: A translational subgroup analysis from AIO-PK0104

PERK, pAKT and p53 as tissue biomarkers in erlotinib-treated patients with advanced pancreatic cancer: A translational subgroup analysis from AIO-PK0104
10    45    1
Elevation of MMP-9 and IDO induced by pancreatic cancer cells mediates natural killer cell dysfunction

Elevation of MMP-9 and IDO induced by pancreatic cancer cells mediates natural killer cell dysfunction
12    38    1
FOLFOX as second-line chemotherapy in patients with pretreated metastatic pancreatic cancer from the FIRGEM study

FOLFOX as second-line chemotherapy in patients with pretreated metastatic pancreatic cancer from the FIRGEM study
8    52    1
Chemotherapy regimens for advanced pancreatic cancer: A systematic review and network meta-analysis

Chemotherapy regimens for advanced pancreatic cancer: A systematic review and network meta-analysis
13    32    1
Validation of four candidate pancreatic cancer serological biomarkers that improve the performance of CA19.9

Validation of four candidate pancreatic cancer serological biomarkers that improve the performance of CA19.9
11    60    1
Metabolic system alterations in pancreatic cancer patient serum: Potential for early detection

Metabolic system alterations in pancreatic cancer patient serum: Potential for early detection
17    80    1
Dimethylaminoparthenolide and gemcitabine: A survival study using a genetically engineered mouse model of pancreatic cancer

Dimethylaminoparthenolide and gemcitabine: A survival study using a genetically engineered mouse model of pancreatic cancer
13    48    1
Metformin-mediated growth inhibition involves suppression of the IGF-I receptor signalling pathway in human pancreatic cancer cells

Metformin-mediated growth inhibition involves suppression of the IGF-I receptor signalling pathway in human pancreatic cancer cells
11    44    1
Association between variations in the fat mass and obesity-associated gene and pancreatic cancer risk: A case - control study in Japan

Association between variations in the fat mass and obesity-associated gene and pancreatic cancer risk: A case - control study in Japan
6    35    1
Upregulation of Wnt5a promotes epithelial-tomesenchymal transition and metastasis of pancreatic cancer cells

Upregulation of Wnt5a promotes epithelial-tomesenchymal transition and metastasis of pancreatic cancer cells
11    48    1
Treatment with a combination of the ErbB (HER) family blocker afatinib and the IGF-IR inhibitor, NVP-AEW541 induces synergistic growth inhibition of human pancreatic cancer cells

Treatment with a combination of the ErbB (HER) family blocker afatinib and the IGF-IR inhibitor, NVP-AEW541 induces synergistic growth inhibition of human pancreatic cancer cells
12    44    1
Type IV collagen stimulates pancreatic cancer cell proliferation, migration, and inhibits apoptosis through an autocrine loop

Type IV collagen stimulates pancreatic cancer cell proliferation, migration, and inhibits apoptosis through an autocrine loop
11    33    1